Clinical Trials Logo
NCT number NCT03188185
Study type Interventional
Source Alkermes, Inc.
Contact Jean-Francois Gagne
Phone 418-407-4627
Email Jean-Francois.Gagne@increasearch.com
Status Recruiting
Phase Phase 3
Start date June 12, 2017
Completion date November 2019

Clinical Trial Summary

This study will evaluate the efficacy, safety, and tolerability of adjunctive ALKS 5461 in adults who have treatment refractory MDD.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


See also
Status Clinical Trial Phase
 Recruiting NCT02939560 - TMS for Adults With Autism and Depression N/A
 Recruiting NCT02309060 - Storytelling Video Intervention for Depressed Primary Care Patients - Open Trial N/A
 Recruiting NCT02674529 - Study of Neural Responses Induced by Antidepressant Effects Phase 2/Phase 3
 Active, not recruiting NCT02934035 - Early Improvement in Individual Symptoms and Response to Antidepressants in Patients With Major Depressive Disorder N/A
 Active, not recruiting NCT02855580 - Integrating Pharmacogenomic Testing Into a Child Psychiatry Clinic N/A
 Not yet recruiting NCT02793258 - Impact of tDCS on Emotional Processing in Major Depression Phase 3
 Not yet recruiting NCT02766920 - Augmentation of Treatment-Resistant Depression With An Analog of the Neuroactive Steroid Allopregnanolone N/A
 Not yet recruiting NCT02871141 - Multimodal Imaging of ECT Effects N/A
 Recruiting NCT03088657 - Design and Methods of the Mood Disorder Cohort Research Consortium (MDCRC) Study N/A
 Recruiting NCT02922556 - Piloting a Novel, Mobile Cognitive Training Tool for Patients With Major Depressive Disorder (MDD) N/A
 Recruiting NCT02624102 - Efficacy of Trial-Based Cognitive Therapy and Behavioral Activation in Treatment of Depression Phase 3
 Recruiting NCT02530164 - Transcranial Direct Current Stimulation (tDCS) As Treatment for Major Depression N/A
 Terminated NCT01613820 - Ketamine and Scopolamine Infusions for Treatment-resistant Major Depressive Disorder N/A
 Not yet recruiting NCT02502604 - Cognitive Training Program for Individuals With Depression and Post-Traumatic Stress Disorder N/A
 Recruiting NCT02078817 - Ketamine in Adolescents With Treatment-Resistant Depression Phase 2
 Recruiting NCT02256566 - Cognitive Training for Mood and Anxiety Disorders Phase 1/Phase 2
 Active, not recruiting NCT01787240 - Neurobiological Bases of Placebo Response in Major Depressive Disorder Phase 4
 Withdrawn NCT02238730 - Ultrabrief Right Unilateral and Brief Pulse Bitemporal Electroconvulsive Therapy N/A
 Completed NCT01851967 - Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans N/A
 Active, not recruiting NCT02185131 - Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD. Phase 2